PATH vs USBC
Uipath Inc (PATH) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. USBC currently screens at market cap $0.
Not investment advice. Open the PATH and USBC stock pages for the full models.
Not investment advice.